204 related articles for article (PubMed ID: 34676775)
21. In silico and in vitro analysis of small molecules and natural compounds targeting the 3CL protease of feline infectious peritonitis virus.
Theerawatanasirikul S; Kuo CJ; Phetcharat N; Lekcharoensuk P
Antiviral Res; 2020 Feb; 174():104697. PubMed ID: 31863793
[TBL] [Abstract][Full Text] [Related]
22. Identification and characterisation of small molecule inhibitors of feline coronavirus replication.
McDonagh P; Sheehy PA; Norris JM
Vet Microbiol; 2014 Dec; 174(3-4):438-447. PubMed ID: 25465182
[TBL] [Abstract][Full Text] [Related]
23. Differential effects of viroporin inhibitors against feline infectious peritonitis virus serotypes I and II.
Takano T; Nakano K; Doki T; Hohdatsu T
Arch Virol; 2015 May; 160(5):1163-70. PubMed ID: 25701212
[TBL] [Abstract][Full Text] [Related]
24. In vitro antiviral activity of circular triple helix forming oligonucleotide RNA towards Feline Infectious Peritonitis virus replication.
Choong OK; Mehrbod P; Tejo BA; Omar AR
Biomed Res Int; 2014; 2014():654712. PubMed ID: 24707494
[TBL] [Abstract][Full Text] [Related]
25. Current status on treatment options for feline infectious peritonitis and SARS-CoV-2 positive cats.
Izes AM; Yu J; Norris JM; Govendir M
Vet Q; 2020 Dec; 40(1):322-330. PubMed ID: 33138721
[TBL] [Abstract][Full Text] [Related]
26. Reverse Genetics for Type I Feline Coronavirus Field Isolate To Study the Molecular Pathogenesis of Feline Infectious Peritonitis.
Ehmann R; Kristen-Burmann C; Bank-Wolf B; König M; Herden C; Hain T; Thiel HJ; Ziebuhr J; Tekes G
mBio; 2018 Jul; 9(4):. PubMed ID: 30065095
[TBL] [Abstract][Full Text] [Related]
27. The influence of age and genetics on natural resistance to experimentally induced feline infectious peritonitis.
Pedersen NC; Liu H; Gandolfi B; Lyons LA
Vet Immunol Immunopathol; 2014 Nov; 162(1-2):33-40. PubMed ID: 25265870
[TBL] [Abstract][Full Text] [Related]
28. Pathogenesis of oral type I feline infectious peritonitis virus (FIPV) infection: Antibody-dependent enhancement infection of cats with type I FIPV via the oral route.
Takano T; Yamada S; Doki T; Hohdatsu T
J Vet Med Sci; 2019 Jun; 81(6):911-915. PubMed ID: 31019150
[TBL] [Abstract][Full Text] [Related]
29. Mutation in spike protein cleavage site and pathogenesis of feline coronavirus.
Licitra BN; Millet JK; Regan AD; Hamilton BS; Rinaldi VD; Duhamel GE; Whittaker GR
Emerg Infect Dis; 2013 Jul; 19(7):1066-73. PubMed ID: 23763835
[TBL] [Abstract][Full Text] [Related]
30. Antiviral treatment using the adenosine nucleoside analogue GS-441524 in cats with clinically diagnosed neurological feline infectious peritonitis.
Dickinson PJ; Bannasch M; Thomasy SM; Murthy VD; Vernau KM; Liepnieks M; Montgomery E; Knickelbein KE; Murphy B; Pedersen NC
J Vet Intern Med; 2020 Jul; 34(4):1587-1593. PubMed ID: 32441826
[TBL] [Abstract][Full Text] [Related]
31. Antibody-dependent enhancement of feline infectious peritonitis virus infection in feline alveolar macrophages and human monocyte cell line U937 by serum of cats experimentally or naturally infected with feline coronavirus.
Hohdatsu T; Yamada M; Tominaga R; Makino K; Kida K; Koyama H
J Vet Med Sci; 1998 Jan; 60(1):49-55. PubMed ID: 9492360
[TBL] [Abstract][Full Text] [Related]
32. Nanoparticulate vacuolar ATPase blocker exhibits potent host-targeted antiviral activity against feline coronavirus.
Hu CJ; Chang WS; Fang ZS; Chen YT; Wang WL; Tsai HH; Chueh LL; Takano T; Hohdatsu T; Chen HW
Sci Rep; 2017 Oct; 7(1):13043. PubMed ID: 29026122
[TBL] [Abstract][Full Text] [Related]
33. Effect of chloroquine on feline infectious peritonitis virus infection in vitro and in vivo.
Takano T; Katoh Y; Doki T; Hohdatsu T
Antiviral Res; 2013 Aug; 99(2):100-7. PubMed ID: 23648708
[TBL] [Abstract][Full Text] [Related]
34. Expression of Toll-like receptors 3, 7, 9 and cytokines in feline infectious peritonitis virus-infected CRFK cells and feline peripheral monocytes.
Megat Mazhar Khair MH; Selvarajah GT; Omar AR; Mustaffa-Kamal F
J Vet Sci; 2022 Mar; 23(2):e27. PubMed ID: 35363438
[TBL] [Abstract][Full Text] [Related]
35. Protection of cats from infectious peritonitis by vaccination with a recombinant raccoon poxvirus expressing the nucleocapsid gene of feline infectious peritonitis virus.
Wasmoen TL; Kadakia NP; Unfer RC; Fickbohm BL; Cook CP; Chu HJ; Acree WM
Adv Exp Med Biol; 1995; 380():221-8. PubMed ID: 8830483
[TBL] [Abstract][Full Text] [Related]
36. Broad-spectrum inhibitors against 3C-like proteases of feline coronaviruses and feline caliciviruses.
Kim Y; Shivanna V; Narayanan S; Prior AM; Weerasekara S; Hua DH; Kankanamalage AC; Groutas WC; Chang KO
J Virol; 2015 May; 89(9):4942-50. PubMed ID: 25694593
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and mutation analysis of the spike protein in feline enteric coronavirus and feline infectious peritonitis detected in household and shelter cats in western Canada.
McKay LA; Meachem M; Snead E; Brannen T; Mutlow N; Ruelle L; Davies JL; van der Meer F
Can J Vet Res; 2020 Jan; 84(1):18-23. PubMed ID: 31949325
[TBL] [Abstract][Full Text] [Related]
38. An outbreak of feline infectious peritonitis in a Taiwanese shelter: epidemiologic and molecular evidence for horizontal transmission of a novel type II feline coronavirus.
Wang YT; Su BL; Hsieh LE; Chueh LL
Vet Res; 2013 Jul; 44(1):57. PubMed ID: 23865689
[TBL] [Abstract][Full Text] [Related]
39. Expression profiles of immune mediators in feline Coronavirus-infected cells and clinical samples of feline Coronavirus-positive cats.
Safi N; Haghani A; Ng SW; Selvarajah GT; Mustaffa-Kamal F; Omar AR
BMC Vet Res; 2017 Apr; 13(1):92. PubMed ID: 28388950
[TBL] [Abstract][Full Text] [Related]
40. Antibody-dependent enhancement occurs upon re-infection with the identical serotype virus in feline infectious peritonitis virus infection.
Takano T; Kawakami C; Yamada S; Satoh R; Hohdatsu T
J Vet Med Sci; 2008 Dec; 70(12):1315-21. PubMed ID: 19122397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
